Notice of reduction of shareholding interest in Company

Current report no. 13/2021

Date of preparation: 28 May 2021
Subject: Notice of reduction of shareholding interest in Company
Legal basis: Article 70 point 1) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) informs that it received from Marek Skibiński, acting on its own behalf and on behalf of his spouse – Aleksandra Skibińska, a notice of reduction of their joint shareholding, as the parties to an implied agreement, to 4.96% of the total number of votes in the Company, drawn up pursuant to Article 69 sec. 1 point 2) in connection with Article 87 sec. 1 point 5) i sec. 4 point 1) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005. The notice constitutes an appendix to this report.